4107 results for «66+video+🫣🫣🫣🫣🫣🫣🫣»

Filter By

4107 results

Improving efficiency in TAVI by implementing an early discharge program

Watch this session with Christian Hengstenberg, Mika Laine & Stefan Toggweiler to learn more which variable need to be take into account for improving efficiency in TAVI by implementing an early discharge program.

This interview supported by Boston Scientific was filmed at PCR Valves e-Course 2020 : see more...

Improving efficiency in TAVI by implementing an early discharge program

What's new on fusion imaging ?

Watch this presentation from Victoria Delgado explaining the use of multimodality imaging in the diagnostic of the patient and listing the new innovative features you can expect in Fusion imaging.

This interview supported by GE Healthcare was filmed at PCR Valves e-Course 2020: see more videos here…

What's new on Fusion imaging?

PCR Valves e-Course 2020 - Exhibitor List

Discover which valued Industry Partners you will be able to interact with in the #PCRvalves virtual Exhibition on 22, 23, 24 November 2020!
PCR Valves e-Course 2020 - Exhibitor List

SMART Trial: Randomized study of Evolut and Sapien in patients with small annuli

Access this discussion between Jeffrey Popma and Didier Tchétché picturing the importance of the SMART trial explaining why now is the time for such trial and detailing the its design and objectives.

This interview supported by Medtronic was filmed at PCR Valves e-Course 2020: see more videos here…

SMART Trial: Randomized study of Evolut and Sapien in patients with small annuli

Removing aspirin from STEMI patients - Can we improve bleeding without compromising on results?

17 May 2022 – From EuroPCR 2022

Watch this EuroPCR 2022 recording by Yoshinobu Onuma, Joanna Wykrzykowska, and Victor Alfonso Jimenez to understand why monotherapy following STEMI can be beneficial for patients, and why aspirin should be eliminated from post-PCI care, and to learn about the ASET SUPREME study.

View more videos and course...

Removing aspirin from STEMI patients - Can we improve bleeding without compromising on results?

Bright future ahead for tricuspid regurgitation management

19 May 2022 – From EuroPCR 2022

In this conversation between Philipp Lurz and Felix Kreidel, recorded for EuroPCR 2022, learn more about the bRIGHT study and the latest outcomes released, and further understand TriClip therapy real-world outcomes applicability in daily practice.

View more videos and course resources here!

Bright future ahead for tricuspid regurgitation management

Transforming clinical trials

17 May 2022 – From EuroPCR 2022

Watch this discussion between Jeffrey Jump and Jochen Reinöhl for EuroPCR 2022 to understand the importance of clinical data in bringing medical innovations to patients in need, the challenges and barriers in today’s landscape, and how the industry is overcoming these hurdles.

View more videos and course...

Transforming clinical trials

Reducing permanent pacemaker implantation for TAVI: techniques to optimise patient outcomes

17 May 2022 – From EuroPCR 2022

Lars Søndergaard, Won-Keun Kim, and Christophe Saint Etienne came together for EuroPCR 2022 to share their experience of implanters achieving single-digit permanent pacemaker implantation: learn about the latest technique and new product features to reduce permanent pacemaker implantation.

View more videos and course resources here!

Reducing permanent pacemaker implantation for TAVI: techniques to optimise patient outcomes

Cordis: 60 years in interventional cardiology

Join Dominique Boulet, VP of Cordis EMEA, as he describes the history of innovations produced by Cordis in interventional cardiology and find out about future innovations to improve patient care…
This interview supported by Cordis was filmed at EuroPCR 2019: see more videos here…

Cordis: 60 years in interventional cardiology

PCR London Valves 2019: LIVE demonstrations

These are the selected centres of excellence that will contribute to this year's LIVE demonstrations. Get detailed information about the corresponding sessions.
LIVE demonstration at PCR London Valves 2019

Results from the DCR4Contrast (Dynamic Coronary Roadmap for Contrast reduction) Trial

16 May 2023 – From EuroPCR 2023

Javier Escaned joins Ajay Kirtane to discuss the DCR4C Trial he conducted, and more specifically to present the main results.

The framework of the study was the contrast reduction during PCI, which is closely related to what is now known as ultra-low contrast PCI, and which mainly concerns particularly...

Results from the DCR4Contrast

Ultra-thin strut stenting to manage challenges in STEMI

17 May 2023 – From EuroPCR 2023

Dilip Kumar and Praveen Chandra discuss the issues and nuances in the treatment of ST-segment elevation myocardial infarction, with a particular focus on the use of ultra-thin strut stents in the treatment of primary angioplasty, or primary STEMI treatment.

After reviewing the situation in India, they take...

Ultra-thin strut stenting

DEFINE FLAIR 5-year and Reveal iFR: learnings on coronary physiology

18 May 2023 – From EuroPCR 2023

Javier Escaned invites Justin Davies and Patrick Serruys to give an update on two trials presented at EuroPCR 2023: DEFINE-FLAIR 5-year follow-up and Reveal iFR.

DEFINE-FLAIR was the largest physiological study of its kind at the time, testing iFR in a non-inferior setting against FFR. The data...

DEFINE FLAIR 5-year and

Multivessel disease, which patients for PCI, CABG or medical treatment?

17 May 2023 – From EuroPCR 2023

Because multivessel disease raises many challenges, cardiac surgeon Lenard Conradi and interventional cardiologist Davide Capodanno discuss the biggest ones.

Is invasive coronary angiography really necessary? If revascularisation is required, which patient should be given a PCI rather than a CABG, and vice versa? What is state-of-the-art in surgery in...

Multivessel disease, which patients for PCI, CABG or medical treatment?

What is the role of imaging and physiology in complex bifurcation PCI?

Gabor Toth and Mariano Pellicano share some thoughts and perspectives on the role of coronary physiology and imaging in complex bifurcation PCI.

While physiology is an invaluable aid in understanding the functional relevance of a stenosis or circumflex bifurcation, imaging is a fantastic tool for understanding anatomy, for monitoring...

What is the role of imaging and physiology in complex bifurcation PCI?

FAITAVI - Major Late-Breaking Trial from EuroPCR 2025

22 May 2025 – From EuroPCR 2025

Presented at EuroPCR 2025, the FAITAVI trial brings new insights into the management of coronary artery disease in patients undergoing TAVI.

In this PCR Perspectives video, Stephan Windecker and Flavio Ribichini explore how the trial—the first of its kind—compared angiography-guided versus FFR-guided strategies for intermediate coronary lesions....

FAITAVI - Major Late-Breaking Trial from EuroPCR 2025

Challenges with re-accessing the coronaries after TAVI

In this short video Guiseppe Tarantini (Italy) summarises some of the challenges associated with repeat coronary angiography and percutaneous coronary intervention (PCI) after transcatheter aortic valve implantation (TAVI). What is the prevalence of coronary artery disease in patients who have undergone TAVI? What proportion of patients...

Re-accessing coronaries

TAVI and stroke prevention

Systematic imaging has shown silent injury to the brain in the vast majority of TAVI patients. Jean-Philippe Collet (France) asks Alexandra Lansky (USA and UK) about the incidence, risk factors and protection in periprocedural stroke. From explaining the mechanical causes and the rates of clinical and...

TAVI and stroke prevention

Clinical use of intracoronary imaging - EAPCI expert consensus

Tom Johnson talks to Giulio Guagliumi about the EAPCI expert consensus document on intracoronary imaging that he presented at EuroPCR 2019. He explains that the document “acknowledges difficulties we as an interventional community have in understanding how best to apply this exciting technology to ensure the...

Clinical use of intracoronary imaging - EAPCI expert consensus

Renal denervation for hypertension treatment: What have we learnt recently?

With the results from 3 recent randomised trials and with 2 technologies, Michel Azizi (France) asks Felix Mahfoud (Germany) about the return of renal denervation not only as a treatment of resistant hypertension but also its use in non-end-stage disease and its application in other fields....

Renal denervation for hypertension treatment: What have we learnt recently?
Didn’t find what you were looking for?